Clinical Study

Day 100 Peripheral Blood Absolute Lymphocyte/Monocyte Ratio and Survival in Classical Hodgkin's Lymphoma Postautologous Peripheral Blood Hematopoietic Stem Cell Transplantation

Figure 1

(a) Receiver operating characteristic curve (ROC) and area under the curve (AUC) for Day 100 absolute lymphocyte count (ALC). (b) -fold cross-validation ROC and AUC for Day 100 ALC. (c) ROC and AUC for Day 100 absolute monocyte count (AMC). (d) -fold cross validation ROC and AUC for Day 100 AMC. (e) ROC and AUC for Day 100 absolute lymphocyte count/absolute monocyte count (ALC/AMC). (f) -fold cross validation ROC and AUC for Day 100 ALC/AMC.
658371.fig.001